Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 775 of 994 entries
View as:

A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00369070 Org: User:
Start: 01/31/07 End: 08/03/11 Due: 08/03/12

Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT02833844 Org: User:
Start: 05/22/17 End: 01/27/20 Due: 01/27/21

A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood

Phase: N/A Priority: Normal
NCT ID: NCT00117442 Org: User:
Start: 08/31/02 End: 12/31/04 Due: 12/31/05

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Phase: N/A Priority: Normal
NCT ID: NCT05378529 Org: User:
Start: 04/19/22 End: 12/30/23 Due: 12/30/24

Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE)

Phase: N/A Priority: Normal
NCT ID: NCT03608657 Org: User:
Start: 07/31/18 End: 03/30/22 Due: 03/30/23

Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT04804553 Org: User:
Start: 03/17/22 End: 12/29/28 Due: 12/29/29

Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01970475 Org: User:
Start: 10/31/13 End: 11/30/14 Due: 11/30/15

Study of Transplant Related Anemia Treated With Aranesp® (STRATA)

Phase: N/A Priority: Normal
NCT ID: NCT00117065 Org: User:
Start: - End: - Due: -

European Union Registry in Paediatric Chronic Kidney Disease Patients Looking at Safety and Usage Patterns of Darbepoetin Alfa

Phase: N/A Priority: Normal
NCT ID: NCT00838097 Org: User:
Start: 02/29/08 End: 02/28/13 Due: 02/28/14

Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00120705 Org: User:
Start: 11/30/02 End: 09/30/03 Due: 09/30/04

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00425204 Org: User:
Start: 03/31/04 End: 03/31/08 Due: 03/31/09

A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01028963 Org: User:
Start: 01/31/10 End: 11/30/10 Due: 11/30/11

ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00101920 Org: User:
Start: 06/30/03 End: 12/31/04 Due: 12/31/05

Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00286091 Org: User:
Start: 01/24/06 End: 04/09/14 Due: 04/09/15

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Phase: N/A Priority: Normal
NCT ID: NCT01290042 Org: User:
Start: 02/28/11 End: 05/31/14 Due: 05/31/15

Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

Phase: N/A Priority: Normal
NCT ID: NCT04303780 Org: User:
Start: 06/04/20 End: 04/27/26 Due: 04/27/27

Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01568866 Org: User:
Start: 06/20/12 End: 02/05/18 Due: 02/05/19

A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria

Phase: N/A Priority: Normal
NCT ID: NCT01440257 Org: User:
Start: 09/30/11 End: 09/30/13 Due: 09/30/14

Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00450658 Org: User:
Start: 03/31/07 End: 10/31/08 Due: 10/31/09

Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04727554 Org: User:
Start: 04/29/21 End: 06/05/23 Due: 06/05/24

Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04117958 Org: User:
Start: 01/20/20 End: 06/01/23 Due: 06/01/24

Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT02662569 Org: User:
Start: 04/14/16 End: 12/06/17 Due: 12/06/18

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a)

Phase: N/A Priority: Normal
NCT ID: NCT03626662 Org: User:
Start: 07/30/18 End: 04/18/23 Due: 04/18/24

Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States

Phase: N/A Priority: Normal
NCT ID: NCT02993120 Org: User:
Start: 12/06/16 End: 08/06/21 Due: 08/06/22

A Trial to Investigate Teprotumumab (High-concentration Formulation) Subcutaneous Administration in Healthy Adult Non-Japanese and Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06674941 Org: User:
Start: 03/24/23 End: 11/14/23 Due: 11/14/24